Big Money Sentiment decreased to 0.95 in Q2 2018. It has change of 0.48, from 2018Q1’s 1.43. The ratio dropped due to NEO positioning: 10 sold and 52 reduced. 27 funds amassed holdings and 32 increased holdings. Investors holded 63.35 million in 2018Q1 but now own 62.47 million shares or 1.39% less. Cubist Systematic Strategies Limited Liability Corp, Connecticut-based fund reported 13,022 shs. Segall Bryant & Hamill Limited Liability Company accumulated 0.07% or 352,664 shs. First Fincl Bank invested in 0.3% or 34,000 shs. Tiaa Cref Investment Lc holds 0% or 249,967 shs in its capital. Rice Hall James & Associates Ltd Co holds 0.12% of its capital in NeoGenomics, Inc. (NASDAQ:NEO) for 243,804 shs. Morgan Stanley accumulated 0% or 129,514 shs. Gabelli Funds Ltd Limited Liability Company owns 361,933 shs or 0.03% of their US capital. Barclays Public Limited Company has invested 0% in NeoGenomics, Inc. (NASDAQ:NEO). Geode Capital Mngmt Ltd Company accumulated 599,446 shs. Vanguard Group stated it has 0% in NeoGenomics, Inc. (NASDAQ:NEO). Blackrock holds 4.15M shs or 0% of its capital. First Light Asset Mgmt Limited Liability Co has 10.54% invested in NeoGenomics, Inc. (NASDAQ:NEO). 21,609 were reported by United Automobile Association. Arrowstreet Partnership invested 0% in NeoGenomics, Inc. (NASDAQ:NEO). Ameritas Investment Partners holds 0% in NeoGenomics, Inc. (NASDAQ:NEO) or 4,132 shs.
NEO registered $12.09 million net activity with 0 buys and 8 insider sales since May 15, 2018. BALLIET JENNIFER also sold $758,100 worth of NeoGenomics, Inc. (NASDAQ:NEO) shs. SHOVLIN ROBERT J. sold $169,786 worth of stock or 12,941 shs.
First Light Asset Management Llc increased its holdings by 8.44% in Neogenomics Inc (NEO), according to 2018Q2 SEC form. 401,731 shares were bought by First Light Asset Management Llc as the company’s stock rose 4.56% with the market. At the end of 2018Q2, the institutional investor held 5.16 million shares of the health care company, priced at $67.68 million, up from 4.76 million at the end of the previous reported quarter. First Light Asset Management Llc has cut its stake in Tandem Diabetes Care Inc and also reduced its holding in Nevro Corp by 50,520 shares in the quarter, for a total of 116,224 shares.
More recent NeoGenomics, Inc. (NASDAQ:NEO) news were brought out by Seekingalpha.com, Globenewswire.com and Seekingalpha.com. The first one has “NeoGenomics beats by $0.03, beats on revenue” as a title and was brought out on October 30, 2018. The next is “NeoGenomics Signs Definitive Agreement to Acquire Genoptix” on October 23, 2018. And last was brought out on October 30, 2018, called “NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q3 2018 Results – Earnings Call Transcript”.
NeoGenomics, Inc. (NASDAQ:NEO) Ratings Coverage
A total of 3 analysts rate NeoGenomics (NASDAQ:NEO) as follows: 3 “Buy”, 0 “Hold” and 0 “Sell”. Тherefore 100% are bullish. (NASDAQ:NEO) has 3 ratings reports on 10 Nov 2018 according to StockzIntelligence. On Tuesday, June 26 the stock of NeoGenomics, Inc. (NASDAQ:NEO) has “Buy” rating given by Stephens. On Wednesday, October 31 the rating was maintained by Raymond James with “Outperform”.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.